Prokaryotic Expression of H1N1 Influenza A Virus Haemagglutinin Protein Globular Domain (HA1)
Archives of Medical Laboratory Sciences,
Vol. 2 No. 3 (2016),
Background: Influenza viruses are a significant cause of morbidity and mortality. The influenza virus pandemics, 1918, 1977, and especially the most recent one, A/H1N1/2009, made evident the need for generating recombinant Influenza H1N1 antigens which are essential to develop both basic and applied research programs. Among influenza virus proteins, haemagglutinin (HA) is a major surface antigen of influenza virus, thus it is highly topical in influenza research and vaccine engineering programs. Alternatively, expression of fragments of the HA (HA1 and HA2) proteins in prokaryotic systems can potentially be the most efficacious strategy for manufacture of large quantities of influenza vaccine in a short period of time.
Materials and Methods: The gene encoding the HA1 protein of the influenza A/Puerto Rico/8/34 was amplified by PCR, then cloned into pTZ57R/T cloning vector. The fidelity of the HA1 open reading frame was confirmed by bidirectional sequencing, then sub-cloned into pET28a prokaryotic expression plasmid, and proteins containing HA1 N-terminally fused to His-Tag were produced in Escherichia coli BL21 through IPTG inducing. The accuracy of the expression was confirmed by running time coursed fraction samples taken before and after the IPTG induction in SDS-PAGE, Western blot analysis were also used for confirmation of the recombinant protein.
Results and Conclusion: The HA1 protein produced here could be considered and evaluated as a protective antigen, which its immunogenicity potential needs to be assessed in animal models along with proper control groups. Moreover, it could be subjected for polyclonal antibody preparation, which, in turn, may be used as an essential material in western blot analyses, as well as in other immunological applications, such as ELISA, immunocytochemistry, immunohistochemistry, and other immunological and serological studies.
- Influenza A
- Prokaryotic Expression
How to Cite
WHO Influenza Fact sheet No. 211 March 2014. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Robbins JB, et al. Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine. 2009;27(44):6234-8.
Redkiewicz P, Sirko A, Kamel KA, Gora-Sochacka A. Plant expression systems for production of hemagglutinin as a vaccine against influenza virus. Acta biochimica Polonica. 2014;61(3):551-60.
Jose´ M. Aguilar-Ya´n˜ ez RP-L, Gonzalo I. Mendoza-Ocho1, Sergio A. Garcı´a-Echaur,Felipe Lo´ pez-Pacheco, David Bulnes-Abundis, Johari Salgado-Gallegos, Itzel M. Lara-Mayorga,Yenny Webb-Vargas, Felipe O. Leo´ n-Angel, Ramo´n E. Rivero-Aranda, Yuriana Oropeza-Almaza´n,Guillermo M. Ruiz-Palacios, Manuel I. Zertuche-Guerra, Rebecca M. DuBois, Stephen W. White,Stacey Schultz-Cherry, Charles J. Russell, Mario M. Alvarez. An Influenza A H1N1 2009 Hemagglutinin Vaccine Produced in Escherichia coli. PloS one. 2010;5.
Davis AR ND, Ueda M, Hiti AL, Dowbenko D, et al. Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in E. coli. Proc Natl Acad Sci USA. 1981;78:5376–80.
Liu D, Si B, Li C, Mi Z, An X, Qin C, et al. Prokaryotic expression and purification of HA1 and HA2 polypeptides for serological analysis of the 2009 pandemic H1N1 influenza virus. Journal of virological methods. 2011;172(1-2):16-21.
Chen J-R, Ma C, Wong C-H. Vaccine design of hemagglutinin glycoprotein against influenza. Trends in Biotechnology. 2011;29(9):426-34.
Qiu D, Tannock GA, Barry RD, Jackson DC. Western blot analysis of antibody responses to influenza virion proteins. Immunology and cell biology. 1992;70 ( Pt 3):181-91.
Huang SS, Lin Z, Banner D, Leon AJ, Paquette SG, Rubin B, et al. Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure. Scientific reports. 2013;3:1698.
Shahsavandi S, Salmanian AH, Ghorashi SA, Masoudi S, Fotouhi F, Ebrahimi MM. Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus. Molecular biology reports. 2011;38(5):3293-8.
Hamilton BS, Whittaker GR, Daniel S. Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses. 2012;4(7):1144-68.
Subbarao K, Murphy BR, Fauci AS. Development of Effective Vaccines against Pandemic Influenza. Immunity. 2006;24(1):5-9.
Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006;312(5772):404-10.
Mozdzanowska K, Feng J, Gerhard W. Virus-Neutralizing Activity Mediated by the Fab Fragment of a Hemagglutinin-Specific Antibody Is Sufficient for the Resolution of Influenza Virus Infection in SCID Mice. Journal of virology. 2003;77(15):8322-8.
Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531-69.
Eisen MB, Sabesan, S., Skehel, J.J., Wiley, D.C. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin–sialyloligosaccharide complexes determined by X-ray crystallography. Virology. 1997;232:19-31.
Shih AC, Hsiao TC, Ho MS, Li WH. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(15):6283-8.
Hoffmann E, Stech J, Guan Y, G.Webster R, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Archives of virology. 2001;146:2275-89.
J. Sambrook DWR. Molecular Cloning: A Laboratory Manual. 3rd ed: Laboratory Press, Cold Spring Harbour, New York; 2001.
Li OT, Poon LL. One step closer to universal influenza epitopes. Expert review of anti-infective therapy. 2009;7(6):687-90.
Shen S, Mahadevappa G, Oh HL, Wee BY, Choi YW, Hwang LA, et al. Comparing the antibody responses against recombinanthemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. Journal of medical virology. 2008;80(11):1972-83.
Mayer M, Buchner J. Refolding of inclusion body proteins. Methods Mol Med. 2004;94:239-54.
Thermo Sientific InsTAclone PCR Cloning Kit #K1213, #K1214. 2012.
Organization WH. Ebola Response Roadmap Situation Report 3, 12 September 2014.
Structural Genomics C, China Structural Genomics C, Northeast Structural Genomics C, Graslund S, Nordlund P, Weigelt J, et al. Protein production and purification. Nature methods. 2008;5(2):135-46.
Alvarez MM, Lopez-Pacheco F, Aguilar-Yanez JM, Portillo-Lara R, Mendoza-Ochoa GI, Garcia-Echauri S, et al. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PloS one. 2010;5(4):e10176.
- Abstract Viewed: 631 times
- PDF Downloaded: 367 times